Nature's Sunshine Products Reports Third Quarter Operating Results

PROVO, Utah--(BUSINESS WIRE)-- Nature's Sunshine Products, Inc. (NASDAQ:NATR), a leading manufacturer and marketer of encapsulated herbs and vitamins, today reported financial operating results for the three and nine month periods ended September 30, 2009.

For the quarter, net sales revenue totaled $85.8 million, compared to $92.7 million for the same three-month period in 2008, a 7.4 percent decline, primarily attributable to the global economic downturn and the adverse effect of foreign currency fluctuations. Operating income increased to $6.2 million in the third quarter of 2009, as compared to $2.1 million in the third quarter of 2008. Net income totaled $2.1 million, compared to a net loss of $0.2 million in the third quarter of last year. Earnings per share were $0.13, compared to a loss of $0.01 per share for the same period last year. These improvements in operating and net income were principally due to reduced expenses and volume incentives.

Total operating expenses were $79.6 million, as compared to $90.6 million in the third quarter of 2008, a 12.1 percent improvement. Selling, general and administrative expenses decreased to $31.2 million from $38.9 million for the same period in the prior year, a 19.8 percent improvement. The Company's balance sheet remained strong, with cash and cash equivalents of $36.3 million and stockholders' equity of $52.7 million as of September 30, 2009. The Company has no long-term debt.

Net sales revenue for the nine months ended September 30, 2009, totaled $253.1 million, compared to $285.0 million for the same period in the prior year, principally due to the global economic downturn and the adverse effect of foreign currency fluctuations. Total operating expenses decreased to $247.7 million compared to $278.7 million for the same period in the prior year primarily as a result of the decrease in net sales. Selling, general and administrative expenses decreased to $103.8 million from $117.9 million in the prior year. Operating income for the nine month period decreased to $5.4 million from $6.3 million year over year, primarily as a result of the decline in net sales. However, net income increased to $2.2 million, or $0.14 per share, from a net loss of $1.3 million, or a loss of $0.08 per share, for the same period in 2008, primarily due to foreign exchange gains in certain markets as well as a decrease in the effective tax rate.

"Despite the recent economic challenges, Nature's Sunshine continues to make progress," said Douglas Faggioli, President and CEO. "Nature's Sunshine Product's domestic sales increased during the current quarter compared to the same quarter last year. Also, we are very encouraged that the number of sales leaders increased over last year. Our annual U.S. convention this year was very successful, with the introduction of a number of exciting new products that have been very well received. Importantly, selling, general and administrative expenses declined as a percentage of net sales revenue, reflecting reduced professional fees and our increased emphasis on cost containment. However, key markets, such as Japan, Russia, Ukraine and Mexico, experienced lower volume, due both to adverse business conditions and unfavorable currency fluctuations related to the strength of the dollar. Finally, the return of our Company's common shares to the NASDAQ Capital Market is another indication of the progress we are making."

Segment Results

In the third quarter, Nature's Sunshine Products US had net sales revenue of $37.6 million, as compared to net sales revenue of $37.3 million during the same period in the prior year. For the nine months ending September 30, 2009, net sales revenue was $113.6 million, compared to $115.4 million for the same period a year ago. This decrease was primarily the result of a generally weaker economy earlier this year compared to the same period a year ago. Selling, general and administrative expenses were $2.4 million lower year over year for the quarter, and declined $2.0 million year over year for the nine-month period. As a result, domestic operating income increased to $2.4 million for the quarter, versus $0.2 million a year ago, and to $5.0 million for the nine-month period, compared to $1.5 million for the same period in 2008.

Nature's Sunshine Products International net sales revenue declined in the quarter to $33.2 million from $41.4 million for the same quarter in the previous year. For the nine-month period, net sales revenue was $98.4 million as compared to $126.7 million for the same period in 2008. The decline in sales revenue was principally the result of the strengthening of the U.S. dollar against foreign currencies in most markets in which NSP International operates, including against the Russian ruble and the Ukrainian hryvnia as compared to the previous year. Operating income for the quarter increased to $3.8 million from $3.0 for the same quarter in 2008. For the nine month period, operating income decreased to $4.9 million from $9.3 million in the same period in the previous year.

Synergy Worldwide net sales revenue for the quarter increased 7.1 percent over the previous year, to $15.0 million from $14.0 million. For the nine-month period, net sales revenue was $41.1 million as compared to $43.0 million in the previous year. The improved sales for the quarter reflected growth in the US, Indonesia and Europe, offset by weaker economic conditions in Japan, as well as the effect of unfavorable foreign currency fluctuations for the quarter and the nine-month period of $0.9 million and $2.1 million, respectively. Synergy had a small operating income for the third quarter, a $1.1 million improvement from an operating loss for the same period a year ago. The operating income in the third quarter reflected the growth in sales in the US, Indonesia and Europe, as well as tighter cost controls. For the nine-month period, Synergy posted an operating loss of $4.4 million, which was unchanged from the same period for the prior year.

As of September 30, 2009, active distributors totaled approximately 695,000, compared to 713,200 as of September 30, 2008, and active managers totaled approximately 28,400, compared to 26,200 a year earlier.

Finally, the Company also announced the preliminary approval of the settlement of its securities class action. As previously disclosed, the Company and certain of its present and former officers and directors are defendants in a consolidated class action filed in the United States District Court for the District of Utah in which the plaintiffs allege violations of federal securities laws. On September 14, 2009, the parties and the Company's directors' and officers' liability insurer signed a Stipulation of Settlement ("Stipulation"). The Stipulation sets forth the complete terms of the parties' proposed settlement. The basic terms of the settlement are that the Company's insurer will pay the settlement class, which is defined as all persons (except for defendants and specified related persons and entities) who purchased the Company's common stock during the period from April 23, 2002 through April 5, 2006, $6 million in exchange for a dismissal with prejudice of the lawsuit and a release of all claims held by members of the settlement class. On October 8, 2009, the Court granted preliminary approval of the Stipulation. Notification of the settlement to class members is now underway. The Court has set a hearing date of February 9, 2010 to determine if the Stipulation should receive final approval.

About Nature's Sunshine Products

Nature's Sunshine Products manufactures and markets through direct sales encapsulated and tableted herbal products, high quality natural vitamins, and other complementary products. In addition to the United States, the Company has operations in Japan, Mexico, Central America, South Korea, Canada, Dominican Republic, Venezuela, Ecuador, Peru, the United Kingdom, Columbia, Brazil, Thailand, Israel, Singapore, Malaysia, Indonesia, the Philippines, Australia, Hong Kong, Taiwan, Russia, Ukraine, Latvia, Lithuania, Kazakhstan, Mongolia, Belarus, China, Poland, Germany, Austria, Norway, Sweden, the Czech Republic and the Netherlands. The Company also has exclusive distribution agreements with selected companies in Argentina, Australia, Chile, New Zealand, and Norway. Additional information can be obtained at the Company's website, www.natr.com.

Cautionary Statement Regarding Forward-Looking Statements

In addition to historical information, this release contains forward-looking statements. Nature's Sunshine may, from time to time, make written or oral forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995. Such statements encompass Nature's Sunshine's beliefs, expectations, hopes, or intentions regarding future events. Words such as "expects," "intends," "believes," "anticipates," "should," "likely," and similar expressions identify forward-looking statements. All forward-looking statements included in this release are made as of the date hereof and are based on information available to the Company as of such date. Nature's Sunshine assumes no obligation to update any forward-looking statement. Actual results will vary, and may vary materially, from those anticipated, estimated, projected or expected for a number of reasons, including, among others: further reviews of the Company's financial statements by the Company and its Audit Committee; modification of the Company's accounting practices; foreign business risks; industry cyclicality; fluctuations in customer demand and order pattern; changes in pricing and general economic conditions; as well as other risks detailed in the Company's previous filings with the SEC.


NATURE'S SUNSHINE PRODUCTS, INC. AND SUBSIDIARIES

CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS

(Amounts in thousands, except per share information)

(Unaudited)

                                                        Three Months Ended
                                                        September 30,

                                                        2009       2008

Net Sales Revenue (net of the rebate portion of volume
incentives

of $11,466 and $12,267, respectively)                   $ 85,777   $ 92,661

Cost and Expenses:

Cost of goods sold                                      17,299     17,146

Volume incentives                                       31,068     34,580

Selling, general and administrative                     31,203     38,864

                                                        79,570     90,590

Operating Income                                        6,207      2,071

Other Income (Expense), Net                             1,300      (448      )

Income Before Provision for Income Taxes                7,507      1,623

Provision for Income Taxes                              5,427      1,789

Net Income (Loss)                                       $ 2,080    $ (166    )

Basic Net Income (Loss) Per Common Share                $ 0.13     $ (0.01   )

Diluted Net Income (Loss) Per Common Share              $ 0.13     $ (0.01   )

Weighted Average Basic Common Shares Outstanding        15,510     15,510

Weighted Average Diluted Common Shares Outstanding      15,510     15,510

                                                        Nine Months Ended
                                                        September 30,

                                                        2009       2008

Net Sales Revenue (net of the rebate portion of volume
incentives

of $34,920 and $38,799, respectively)                   $ 253,102  $ 285,023

Cost and Expenses:

Cost of goods sold                                      50,633     53,159

Volume incentives                                       93,281     107,634

Selling, general and administrative                     103,769    117,882

                                                        247,683    278,675

Operating Income                                        5,419      6,348

Other Income (Expense), Net                             3,048      (495      )

Income Before Provision for Income Taxes                8,467      5,853

Provision for Income Taxes                              6,315      7,163

Net Income (Loss)                                       $ 2,152    $ (1,310  )

Basic Net Income (Loss) Per Common Share                $ 0.14     $ (0.08   )

Diluted Net Income (Loss) Per Common Share              $ 0.14     $ (0.08   )

Weighted Average Basic Common Shares Outstanding        15,510     15,510

Weighted Average Diluted Common Shares Outstanding      15,510     15,510




NATURE'S SUNSHINE PRODUCTS, INC. AND SUBSIDIARIES

CONDENSED CONSOLIDATED BALANCE SHEETS

(Amounts in thousands)

(Unaudited)

                                                September 30,    December 31,
                                                2009             2008

Assets

Current Assets:

Cash and cash equivalents                       $ 36,263         $ 34,853

Accounts receivable, net of allowance for
doubtful accounts

of $1,779 and $1,472, respectively              11,921           10,786

Investments available for sale                  3,370            3,858

Restricted investments                          --               2,050

Inventories, net                                40,640           39,558

Deferred income tax assets                      9,568            9,080

Prepaid expenses and other current assets       8,205            7,935

Total current assets                            109,967          108,120

Property, plant and equipment, net              28,945           30,224

Investment securities                           1,646            1,394

Intangible assets                               1,450            1,538

Deferred income tax assets                      6,558            6,412

Other assets                                    16,431           16,588

                                                $ 164,997        $ 164,276

Liabilities and Shareholders' Equity

Current Liabilities:

Accounts payable                                $ 7,498          $ 8,777

Accrued volume incentives                       18,272           15,753

Accrued liabilities                             41,690           45,475

Deferred revenue                                4,249            5,167

Income taxes payable                            3,999            2,748

Total current liabilities                       75,708           77,920

Liability related to unrecognized tax benefits  31,676           30,952

Deferred compensation payable                   1,646            1,394

Other liabilities                               3,219            333

Total long-term liabilities                     36,541           32,679

Shareholders' Equity:

Common Stock, no par value; 20,000 shares
authorized, 15,510

shares issued and outstanding as of September
30, 2009 and

December 31, 2008                               66,705           66,705

Retained earnings                               5,548            4,172

Accumulated other comprehensive loss            (19,505       )  (17,200      )

Total shareholders' equity                      52,748           53,677

                                                $ 164,997        $ 164,276




NATURE'S SUNSHINE PRODUCTS, INC. AND SUBSIDIARIES

CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS

(Amounts in thousands)

(Unaudited)

                                                          Nine Months Ended
                                                          September 30,

                                                          2009        2008

CASH FLOWS FROM OPERATING ACTIVITIES:

Net income (loss)                                         $ 2,152     $ (1,310 )

Adjustments to reconcile net income (loss) to net cash
provided by operating activities:

Provision for doubtful accounts                           129         1,027

Depreciation and amortization                             3,425       4,381

Share-based compensation expense                          --          86

Loss on sale of property and equipment                    140         62

Deferred income taxes                                     (361     )  (531     )

Amortization of bond discount                             21          29

Purchase of trading investment securities                 (169     )  (119     )

Proceeds from sale of trading investment securities       65          78

Realized and unrealized (gains) losses on investments     (194     )  261

Amortization of prepaid taxes related to gain on          911         942
intercompany sales

Foreign exchange gains                                    (2,268   )  (100     )

Changes in assets and liabilities:

Accounts receivable                                       (1,043   )  (1,207   )

Inventories                                               (696     )  (3,523   )

Prepaid expenses and other current assets                 (196     )  (1,843   )

Other assets                                              (283     )  (942     )

Accounts payable                                          (946     )  1,299

Accrued volume incentives                                 2,226       1,591

Accrued liabilities                                       (3,239   )  2,614

Deferred revenue                                          (918     )  (1,773   )

Income taxes payable                                      1,235       2,745

Liability related to unrecognized tax positions           724         187

Deferred compensation payable                             252         (137     )

Net cash provided by operating activities                 967         3,817

CASH FLOWS FROM INVESTING ACTIVITIES:

Purchases of property, plant and equipment                (2,452   )  (6,767   )

Proceeds from sale of investments available for sale      600         640

Purchases of investments available for sale               (5       )  --

Proceeds from sale of restricted investments              2,050       25

Proceeds from sale of property, plant and equipment       53          79

Net cash provided by (used in) investing activities       246         (6,023   )

CASH FLOWS FROM FINANCING ACTIVITIES:

Payment of cash dividends                                 (776     )  (2,327   )

Proceeds from short-term borrowings                       7,900       --

Payments on short-term borrowings                         (7,900   )  --

Net cash used in financing activities                     (776     )  (2,327   )

Effect of exchange rates on cash and cash equivalents     973         (880     )

Net increase (decrease) in cash and cash equivalents      1,410       (5,413   )

Cash and cash equivalents at the beginning of the period  34,853      45,299

Cash and cash equivalents at end of the period            $ 36,263    $ 39,886

SUPPLEMENTAL DISCLOSURE OF CASH FLOW INFORMATION:

Cash paid for income taxes                                $ 6,004     $ 2,169

Cash paid for interest                                    $ 69        $ 59




    Source: Nature's Sunshine Products, Inc.